Reportedly, allicin directly inhibits the IL-17A/F-induced STAT3/NF-κB and TRAF6/MAPK/NF-κB signaling cascades in keratinocytes, thereby attenuating pro-inflammatory feedback and ameliorating psoriasis-like dermatitis [50]. The gene discussed is IL17A; the disease is skin disorder.